Customize
Quick Links

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by medical education grants from Eisai, Inc. and Exelixis, Inc.

Not an official event of the 2018 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO, CancerLinQ, or the Conquer Cancer Foundation.

About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

ASCO: Navigating New Sequencing Challenges for the Treatment of Hepatocellular Carcinoma

ASCO: Navigating New Sequencing Challenges for the Treatment of Hepatocellular Carcinoma


Sunday, June 3, 2018
Time: 7:00 PM – 9:00 PM
Dinner and registration: 6:30 PM – 7:00 PM

Hilton Chicago
International Ballroom South (Second Level)
720 South Michigan Avenue
Chicago, IL 60605

Overview

Historically, hepatocellular carcinoma (HCC) has been associated with poor outcomes, due in large part to the few effective treatment options available to patients who are ineligible for curative therapy. However, recent approvals and emerging strategies for HCC are transforming patient care and improving patient outcomes. Are you ready to incorporate new approaches and information into your practice?

Please join us at Navigating New Sequencing Challenges for the Treatment of Hepatocellular Carcinoma, a satellite symposium being held in Chicago in June 2018. This program is designed to help you assess the latest available safety and efficacy data related to the care of patients with HCC.

At this lively, interactive, case-based symposium, a panel of renowned experts in HCC will guide you through an exploration of evidence-based rationales for treatment choices at key decision points along the HCC continuum. You will get an up-close look at how the faculty leverage key data sets to support decision making on treatment initiation, sequencing, monitoring, and switching, as well as adverse event management.

By participating in this exciting program, you will learn about:

  • Evolving natural history of HCC and how it is changing patient care
  • Biology and mechanisms of action of newer targeted agents for HCC
  • Key clinical trial data that are changing how patients with HCC are treated
  • Integrating new therapeutic options into your care plans for patients with HCC

Acknowledgment of Commercial Support

This activity is supported by medical education grants from Eisai, Inc. and Exelixis, Inc.

Target Audience

This educational program is directed toward medical, surgical, and radiation oncologists involved in the treatment of patients with HCC. Nurse practitioners, physician assistants, nurses, and other healthcare professionals interested in the treatment and management of patients with HCC are invited to participate.

Learning Objectives

Upon completion of this activity, participants should be better prepared to:

  1. Describe how the natural history of HCC is evolving, and the implications of these changes for patients and the practitioners who manage patients with these tumors
  2. Explain the biology and mechanistic rationale that underlie recent targeted drug development in HCC
  3. Evaluate efficacy and safety outcomes from practice-changing clinical trials conducted in patients with HCC
  4. Apply recent evidence and patient characteristics to inform optimized sequencing decisions in the management of patients with HCC

Program Chair

Alan P. Venook, MD, FASCO
Madden Family Distinguished Professor in Medical Oncology and Translational Research
Shorenstein Associate Director, Program Development
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, CA

Click to see all our ASCO programs!







Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
  12345
6789101112
13141516171819
20212223242526
2728293031
Filter By